Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
11 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The Nasdaq composite fell 1.3% in a mixed session as AI-related shares slid after reports of lower-than-expected OpenAI revenue. Oil prices rose after President Donald Trump's remarks on the Middle East war, while Federal Reserve Gov. Christopher Waller said additional rate hikes may be needed.
Bitcoin moved down to around $81,500 in afternoon trade as major U.S. stock indexes stayed lower and Treasury yields eased. The move came alongside broader risk-off action tied to oil, Fed comments and tech-sector weakness.
Bitcoin fell to around $81,500 in afternoon trade as broader markets reacted to higher oil prices and hawkish Federal Reserve comments.
Dow Jones futures fell, alongside S&P 500 and Nasdaq futures, as the 10-year Treasury yield rose to 5.33%. The note also said the S&P 500 and Nasdaq composite had hit fresh highs in Tuesday trading.
By Ed Carson Dow Jones futures fell modestly early Wednesday, along with S&P 500 futures and Nasdaq futures as Treasury yields rose. The stock market rally continued to advance Tuesday with the S&P 500 hitting a new high, joining the Nasdaq composite, as yields declined. The major indexes did pare intraday gains, while
bioAffinity Technologies reported sales of its CyPath Lung test for lung cancer increased more than 100% through the third quarter of 2026 compared to 2025. The number of ordering physicians increased by 89% in Q3 2026 compared to Q3 2025.
Insmed (NASDAQ: INSM ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Insmed reported strong
Henry Schein (NASDAQ: HSIC ) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Henry Schein Inc reported strong financial performance in the se
It is a make-or-break week for the AI trade. After the market shrugged off strong results from Advanced Micro Devices Inc. (NASDAQ: AMD ), SanDisk Corp. (NASDAQ: SNDK ) and Western Digital Corp. (NASDAQ: WDC ) last week, a smaller but no less volatile group of names takes the spotlight between Monday and Friday. The he
SELLAS Life Sciences Group Inc (NASDAQ: SLS ) shares are trading lower Tuesday as traders digest the recent breakout run and early profit-taking shows up even with momentum still elevated from the company’s latest corporate update. SELLAS Life Sciences shares are retreating from recent levels. Why is SLS stock dropping
Historical trends suggest a potential surge in a biotech stock currently trading near $50. This could be a buying opportunity for investors.